The demand for probiotic supplement items in Western Europe is expected to generate a revenue of around USD 1,038.52 million in 2023. The regional demand for probiotic supplement derived from bacteria and fungi is poised to increase at a CAGR of 8.4% between 2023 and 2033. The total value of all probiotic supplement industries in Western Europe is expected to reach USD 2,327.12 million by 2033.
Key Trends behind the Surge in Revenues by Probiotic Supplement Industry
| Attributes | Details |
|---|---|
| Industry Size of Western Europe in 2023 | USD 1,038.52 million |
| Expected Industry Size of Western Europe by 2033 | USD 2,327.12 million |
| Forecasted CAGR between 2023 to 2033 | 8.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The vast culinary diversity and cultural acceptance of fermented foods in different Western European countries promote the recognition of probiotics in pure form. The growing practice of consuming probiotics supplement in simple and concentrated supplies to improve digestive health presents lucrative growth opportunities in the region.
In many Western European countries, the demand for different types of nutraceuticals and functional foods has increased significantly in recent years. The consumption of probiotic supplement is growing more swiftly as consumers recognize it to provide both nutritional and functional benefits.
Probiotic supplement are easily accessible in Western Europe due to the extensive use of eCommerce which also favors manufacturers for better reach and product visibility. By taking advantage of targeted marketing tactics and direct-to-consumer sales made possible by eCommerce websites, pharmaceutical companies have been able to develop quickly in this sector.
The demand for probiotic supplement among women in Western Europe is estimated to make up 43.6% of the industry share in 2023.
| Leading End User for Probiotic Supplement in Western Europe | Women |
|---|---|
| Total Value Share (2023) | 43.6% |
Probiotic pills, as useful and health-improving goods, fit well into women's busy schedules and changing dietary choices during pregnancy. However, the growing adoption of probiotic supplement to help with age-related digestive problems and boost immunity is expected to drive demand in other end user segments.
According to the analysis report, the share of lactobacillus in the overall industry could be 37.9% in 2023.
| Leading Bacteria Type for Probiotic Supplement in Western Europe | Lactobacillus |
|---|---|
| Total Value Share (2023) | 37.9% |
Several advantages of lactobacillus for gut health are backed by scientific research, which has led to a strong demand for them in Western European countries. Since consumers consider the prevention of digestive problems as an integral element of maintaining good health, this segment has consistently retained its dominance in the region.
Principal Consultant
| Key Countries in Western Europe | Value CAGR (2023 to 2033) |
|---|---|
| Netherlands | 9.1% |
| United Kingdom | 8.5% |
| France | 7.9% |
The demand for probiotic supplement in the Netherlands is forecasted to develop at 9.1% CAGR during the projected timeline.
The regulatory framework in place for the use of probiotic supplement by food and beverage industries fosters customer trust and is anticipated to promote and expedite the industry's growth. For example, the Netherlands Food and Drug Administration published guidelines in March 2021 to mention "probiotics" as essential data on food and supplement labels.
Over the forecasted years, the sales of probiotic supplement in the United Kingdom are projected to rise at 8.5% CAGR.
Producers of probiotic supplement in the United Kingdom have the advantage of a consumer base with a better understanding of the unique health benefits of their goods. Moreover, many probiotic supplement have established international supply chains that could play a pivotal role in the further growth of the industry.
The probiotic supplement industry in France is anticipated to expand at a 7.9% compound annual growth rate per year between 2023 and 2033.
In France, consumers are significantly influenced by the endorsements, testimonies, and suggestions of health experts regarding the use of supplement and functional foods. So, probiotic supplement suppliers in the country are using targeted advertisement and instructional initiatives to create an atmosphere that is favorable for their products.
The probiotic supplement industry in Western Europe is highly concentrated, with a few dominant companies including Nestle, BioGaia, and Sinbiotic holding a significant revenue share. In recent years, these leading players have further solidified their places by releasing consumer-oriented products in packaged form. On the other hand, smaller companies in this sector have prioritized probiotic research and innovations to serve a diverse clientele and enhance their brand recognition.
Recent Developments by Probiotic Supplement Industries in Western Europe
In May 2023, Roquette expanded the health and nutrition industry toward a more flexible, reliable, and consumer-focused future for probiotic supplement with the introduction of PEARLITOL® ProTec. This new excipient is a novel plant-based co-processed combination of mannitol and maize starch which stabilizes and extends the shelf life of active probiotics that are sensitive to moisture.
In August 2022, BioGaia Campany declared to add new bacterial strains to its product lineup, which it would be developing in partnership with its subsidiary MetaboGen. The two companies are also working together to construct a fermentation pilot facility in Eslöv to develop these novel strains through clinical trials.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2023 | USD 1,038.52 million |
| Projected Industry Size by 2033 | USD 2,327.12 million |
| Anticipated CAGR between 2023 to 2033 | 8.4% CAGR |
| Historical Analysis of Demand for Probiotic Supplement in Western Europe | 2018 to 2022 |
| Demand Forecast for Probiotic Supplement in Western Europe | 2023 to 2033 |
| Report Coverage | Industry Size, Industry Trends, Analysis of key factors influencing Probiotic Supplement Adoption in Western Europe, Insights on Global Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Manufacturers |
| Key Countries Analyzed while Studying Opportunities in Probiotic Supplement in Western Europe | Germany, Italy, France, Spain, United Kingdom, BENELUX, Rest of Western Europe |
| Key Companies Profiled | Alphanova (France); Altaïcare (France); Arkopharma (France); Arla Foods (Denmark); Atida Sweden (Sweden); BioGaia (Sweden); Danone (France); Dr. Willmar Schwabe (Germany); Embark Holdings (United Kingdom); Galderma (Switzerland); GlaxoSmithKline (United Kingdom); Herbapol (Poland); Hero Group (Spain); Holland & Barrett (United Kingdom); Innova Biosciences (Spain); Kerry Group (Ireland); Nestlé (Switzerland); New Nordic (Denmark); Nutraingredients (United Kingdom); Orkla Health (Norway); Pharma Nord (Denmark); Procter & Gamble (United States); Proderna (Belgium); Provita (Spain); Qiagen (Germany); Reckitt Benckiser (United Kingdom); Synbiotic International (United Kingdom); Valio (Finland); Vitabiotics (United Kingdom); Wessanen (Netherlands) |
The expected CAGR for the industry in Western Europe through 2033 is 8.4%.
The anticipated demand in Western Europe is likely to reach USD 2,327.12 million by 2033.
The rising popularity of supplement in chewable form has impacted the regional sales.
Probiotic supplement manufacturers are emphasizing more on promotional activities.
Women are set to account for 43.6% of overall demand across Western Europe in 2023.
1. Executive Summary 2. Market Overview 3. Market Background 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Bacteria 5.1. Lactobacillus 5.2. Streptococcus 5.3. Bifid bacterium 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form 6.1. Tablet 6.2. Capsules 6.3. Liquid 6.4. Powder Premixes 6.5. Gummies/Chewable 6.6. Lozenges 6.7. Liquid & Gels 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Function 7.1. Immunity & Digestive Health 7.2. Urogenital Health 7.3. Vaginal Health 7.4. Urinary Tract Infections 7.5. Pregnancy 7.6. Weight Management 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Hypermarket/ Supermarket 8.2. Specialty Stores 8.3. E-Commerce 8.4. Pharmacy Stores 9. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End User 9.1. Women 9.2. Seniors 9.3. Kids 10. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. UK 10.2. Germany 10.3. Italy 10.4. France 10.5. Spain 10.6. Rest of Western Europe 11. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 12. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 13. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 14. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 15. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 16. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 17. Market Structure Analysis 18. Competition Analysis 18.1. Bio-Kult 18.2. Optibac Probiotics 18.3. Symprove 18.4. ProVen Probiotics 18.5. Sanofi 18.6. Jarrow Formulas 18.7. NOVA Probiotics 18.8. Lifeway Foods 18.9. Total Nutrition, Inc. 18.10. Pharma Care Laboratories 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Demand and Trend Analysis of Probiotic Supplement in Western Europe
